"In Vitro Techniques" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Methods to study reactions or processes taking place in an artificial environment outside the living organism.
| Descriptor ID |
D066298
|
| MeSH Number(s) |
E05.481
|
| Concept/Terms |
In Vitro Techniques- In Vitro Techniques
- In Vitro Technique
- Technique, In Vitro
- Techniques, In Vitro
- In Vitro as Topic
|
Below are MeSH descriptors whose meaning is more general than "In Vitro Techniques".
Below are MeSH descriptors whose meaning is more specific than "In Vitro Techniques".
This graph shows the total number of publications written about "In Vitro Techniques" by people in this website by year, and whether "In Vitro Techniques" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 1 | 1 |
| 1995 | 0 | 4 | 4 |
| 1997 | 0 | 1 | 1 |
| 1998 | 0 | 1 | 1 |
| 1999 | 0 | 1 | 1 |
| 2000 | 0 | 2 | 2 |
| 2002 | 0 | 4 | 4 |
| 2003 | 0 | 6 | 6 |
| 2004 | 0 | 6 | 6 |
| 2005 | 0 | 10 | 10 |
| 2006 | 0 | 4 | 4 |
| 2007 | 0 | 2 | 2 |
| 2008 | 0 | 2 | 2 |
| 2009 | 0 | 1 | 1 |
| 2010 | 0 | 4 | 4 |
| 2011 | 0 | 1 | 1 |
| 2012 | 0 | 2 | 2 |
| 2013 | 0 | 4 | 4 |
| 2014 | 0 | 6 | 6 |
| 2015 | 0 | 4 | 4 |
| 2016 | 0 | 3 | 3 |
| 2017 | 1 | 39 | 40 |
| 2018 | 1 | 50 | 51 |
| 2019 | 2 | 17 | 19 |
| 2020 | 0 | 20 | 20 |
| 2021 | 1 | 13 | 14 |
To return to the timeline, click here.
Below are the most recent publications written about "In Vitro Techniques" by people in Profiles.
-
Scutellaria baicalensis extract and baicalein inhibit replication of SARS-CoV-2 and its 3C-like protease in vitro. J Enzyme Inhib Med Chem. 2021 Dec; 36(1):497-503.
-
Fluorogenic in vitro activity assay for the main protease Mpro from SARS-CoV-2 and its adaptation to the identification of inhibitors. STAR Protoc. 2021 09 17; 2(3):100793.
-
Harnessing the power of microphysiological systems for COVID-19 research. Drug Discov Today. 2021 11; 26(11):2496-2501.
-
A non-RBM targeted RBD specific antibody neutralizes SARS-CoV-2 inducing S1 shedding. Biochem Biophys Res Commun. 2021 09 24; 571:152-158.
-
Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp15 endoribonuclease. Biochem J. 2021 07 16; 478(13):2465-2479.
-
Human microRNA hsa-miR-15b-5p targets the RNA template component of the RNA-dependent RNA polymerase structure in severe acute respiratory syndrome coronavirus 2. Nucleosides Nucleotides Nucleic Acids. 2021; 40(8):790-797.
-
Mild COVID-19 despite autoantibodies against type I IFNs in autoimmune polyendocrine syndrome type 1. J Clin Invest. 2021 07 15; 131(14).
-
Variable Induction of Pro-Inflammatory Cytokines by Commercial SARS CoV-2 Spike Protein Reagents: Potential Impacts of LPS on In Vitro Modeling and Pathogenic Mechanisms In Vivo. Int J Mol Sci. 2021 Jul 14; 22(14).
-
Long-chain polyphosphates impair SARS-CoV-2 infection and replication. Sci Signal. 2021 07 06; 14(690).
-
IFN-?+ cell response and IFN-? release concordance after in vitro SARS-CoV-2 stimulation. Eur J Clin Invest. 2021 Dec; 51(12):e13636.